Skip to main content

Table 6 Process and outcome indicators at baseline and follow-up for subgroups by gender, % (n/N)

From: Capacity building of health care professionals to perform interprofessional management of non-communicable diseases in primary care – experiences from Ukraine

Characteristica Intervention Control Inter-action
  Baseline Follow-up OR (95% CI)** p-value** Baseline Follow-up OR (95% CI)** p-value** p-value**
Women
 CVD patients
  Statin prescribed 39.1 (382/978) 54.6 (574/1051) 1.86 (1.56–2.22) < 0.001 24.3 (78/321) 33.0 (107/324) 1.53 (1.08–2.16) 0.016 0.314
  HT drug prescribed 90.3 (883/978) 93.1 (978/1051) 1.43 (1.04–1.96) 0.029 81.0 (260/321) 86.1 (279/324) 1.43 (0.94–2.19) 0.096 0.959
  TC documented 33.5 (328/978) 60.2 (633/1051) 3.07 (2.56–3.69) < 0.001 24.3 (78/321) 28.1 (91/324) 1.25 (0.87–1.78) 0.224 < 0.001
  TC at normal range 30.5 (100/328) 34.4 (218/633) 1.20 (0.90–1.60) 0.215 29.5 (23/78) 48.4 (44/91) 2.18 (1.15–4.15) 0.017 0.078
 HT patients
  HT drug prescribed 93.5 (1030/1102) 96.0 (1127/1174) 1.67 (1.15–2.44) 0.008 85.2 (339/398) 89.7 (366/408) 1.46 (0.95–2.23) 0.084 0.710
  BP control 15.2 (134/882) 12.1 (120/995) 0.77 (0.59–1.01) 0.055 10.4 (33/316) 13.2 (46/348) 1.32 (0.82–2.12) 0.255 0.054
 DM patients
  HbA1c documented 21.4 (49/229) 27.1 (71/262) 1.44 (0.95–2.20) 0.089 9.3 (5/54) 10.7 (9/84) 1.15 (0.36–3.65) 0.817 0.720
  FG documented 91.7 (210/229) 92.4 (242/262) 1.16 (0.60–2.25) 0.656 77.8 (42/54) 89.3 (75/84) 2.37 (0.92–6.12) 0.076 0.231
  TC documented 41.9 (96/229) 64.1 (168/262) 2.48 (1.72–3.57) < 0.001 29.6 (16/54) 34.5 (29/84) 1.24 (0.59–2.60) 0.563 0.101
  Statin prescribed 49.8 (114/229) 59.2 (155/262) 1.45 (1.01–2.08) 0.043 24.1 (13/54) 32.1 (27/84) 1.52 (0.70–3.31) 0.291 0.924
  BP control 2.7 (6/226) 4.7 (12/258) 1.89 (0.70–5.14) 0.212 9.8 (5/51) 6.0 (5/84) 0.58 (0.16–2.12) 0.412 0.168
  FG control 35.2 (74/210) 40.5 (98/242) 1.20 (0.82–1.77) 0.352 47.6 (20/42) 44.0 (33/75) 0.89 (0.41–1.90) 0.755 0.484
  TC at normal range 29.2 (28/96) 30.4 (51/168) 1.01 (0.58–1.76) 0.979 12.5 (2/16) 37.9 (11/29) 4.36 (0.82–23.21) 0.085 0.089
Men
 CVD patients
  Statin prescribed 47.9 (395/825) 56.3 (502/891) 1.39 (1.15–1.69) 0.001 30.7 (79/257) 43.0 (120/279) 1.66 (1.16–2.37) 0.006 0.390
  HT drug prescribed 87.0 (718/825) 90.1 (803/891) 1.36 (1.01–1.83) 0.046 76.3 (196/257) 84.9 (237/279) 1.68 (1.08–2.61) 0.020 0.364
  TC documented 35.8 (295/825) 60.8 (542/891) 2.85 (2.34–3.47) < 0.001 25.2 (65/257) 33.7 (94/279) 1.65 (1.12–2.42) 0.011 0.006
  TC at normal range 41.0 (121/295) 43.9 (238/542) 1.12 (0.84–1.50) 0.435 49.2 (32/65) 50.0 (47/94) 1.01 (0.54–1.91) 0.969 0.793
 HT patients
  HT drug prescribed 91.6 (846/924) 94.5 (924/978) 1.56 (1.09–2.24) 0.015 82.9 (271/327) 89.2 (313/351) 1.58 (1.01–2.47) 0.046 0.863
  BP control 14.8 (104/705) 15.6 (126/806) 1.08 (0.82–1.44) 0.578 9.6 (24/250) 13.8 (42/305) 1.53 (0.89–2.60) 0.122 0.254
 DM patients
  HbA1c documented 21.2 (33/156) 27.1 (52/192) 1.40 (0.84–2.31) 0.194 9.8 (5/51) 15.9 (11/69) 2.13 (0.67–6.80) 0.203 0.565
  FG documented 83.3 (130/156) 91.1 (175/192) 2.06 (1.07–3.95) 0.030 86.3 (44/51) 79.7 (55/69) 0.65 (0.24–1.78) 0.402 0.055
  TC documented 46.2 (72/156) 70.3 (135/192) 2.78 (1.78–4.32) < 0.001 49.0 (25/51) 42.0 (29/69) 0.82 (0.39–1.73) 0.607 0.004
  Statin prescribed 57.7 (90/156) 62.5 (120/192) 1.22 (0.79–1.89) 0.361 31.4 (16/51) 43.5 (30/69) 1.62 (0.75–3.48) 0.222 0.578
  BP control 6.5 (10/153) 7.8 (15/192) 1.22 (0.53–2.80) 0.647 2.1 (1/47) 6.0 (4/67) 3.36 (0.35–32.02) 0.292 0.521
  FG control 38.5 (50/130) 38.9 (68/175) 1.02 (0.64–1.64) 0.925 47.7 (21/44) 40.0 (22/55) 0.76 (0.34–1.69) 0.496 0.425
  TC at normal range 41.7 (30/72) 34.1 (46/135) 0.72 (0.40–1.31) 0.283 36.0 (9/25) 27.6 (8/29) 0.62 (0.19–2.00) 0.420 0.873
  1. Abbreviations: CVD cardiovascular disease; HT hypertension; TC total cholesterol; BP blood pressure; DM diabetes mellitus; HbA1c glycated haemoglobin; FG fasting glucose; OR odds ratio; CI confidence interval
  2. aTC documented = Proportion of patients in the defined patient group with at least one documented total cholesterol measurement; Statin prescribed = Proportion of patients in the defined patient groups with stating prescribed; HT drug prescribed = Proportion of patients in the defined patient group prescribed blood pressure lowering drug; TC at normal range = Proportion of patients with cardiovascular disease whose last total cholesterol measurement was < 5 mmol/l; HT patients with BP control = Proportion of confirmed hypertensive patients whose last two blood pressure measurements were controlled (SBP < 140 mmHg and DBP < 90 mmHg), of which at least the most recent one during the last 12 months; DM patients with BP control = Proportion of diabetic patients whose last recorded blood pressure measurement was at normal range (systolic blood pressure < 130 mmHg and diastolic blood pressure < 80 mmHg); DM patients with FG control = Proportion of patients whose last fasting glucose measurement was < 7 mmol/l
  3. ** Age adjusted